Polar Capital Global Healthcare Trust (LSE: PCGH), is a large British investment trust focused on investments in the health sector. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[1]
History
The company was established as Polar Capital Global Healthcare Growth and Income Trust in May 2010 and adopted its current name in June 2017.[2] As of August 2025, its largest investments included AstraZeneca, Eli Lilly and Company and UnitedHealth Group.[3]
In October 2025, the company asked investors to change the status of the trust from that with a limited term of eight years to one with an unlimited life, but with the opportunity for investors to exit the trust every five years.[4][5][6]
It is managed by Polar Capital and the chair is Lisa Arnold.[7]
References
- ↑ "Diversified Energy Company (UK): Reorganisation – Update Changes in FTSE UK Index Series". FTSE Russell. 19 November 2025. Retrieved 19 November 2025.
- ↑ "Polar Capital Global Healthcare Trust". Companies House. Retrieved 19 November 2025.
- ↑ "The only two trusts run by Alpha Managers with top Crown ratings". Trust.net. 27 August 2025. Retrieved 19 November 2025.
- ↑ "Top performer Polar Capital Global Healthcare looks for minimum £270m to continue after its relaunch". Quoted Data. 23 October 2025. Retrieved 19 November 2025.
- ↑ "Healthcare sector at an inflection point: The investment case for Polar Capital Global Healthcare Trust". UK Investor Magazine. 5 November 2025. Retrieved 19 November 2025.
- ↑ "Healthcare trusts forced to rethink discount strategies". Investors Chronicle. 18 June 2025. Retrieved 19 November 2025.
- ↑ "Future of the Company". The Association of Investment Companies. Retrieved 19 November 2025.